DD236093A5 - Verfahren zur herstellung von 1,4-dihydropyridinen - Google Patents
Verfahren zur herstellung von 1,4-dihydropyridinen Download PDFInfo
- Publication number
- DD236093A5 DD236093A5 DD85279811A DD27981185A DD236093A5 DD 236093 A5 DD236093 A5 DD 236093A5 DD 85279811 A DD85279811 A DD 85279811A DD 27981185 A DD27981185 A DD 27981185A DD 236093 A5 DD236093 A5 DD 236093A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- methyl
- general formula
- compound
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848421039A GB8421039D0 (en) | 1984-08-17 | 1984-08-17 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DD236093A5 true DD236093A5 (de) | 1986-05-28 |
Family
ID=10565527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD85279811A DD236093A5 (de) | 1984-08-17 | 1985-08-19 | Verfahren zur herstellung von 1,4-dihydropyridinen |
Country Status (5)
Country | Link |
---|---|
US (2) | US4694012A (es) |
DD (1) | DD236093A5 (es) |
GB (3) | GB8421039D0 (es) |
MX (1) | MX5840A (es) |
ZA (1) | ZA855910B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4968703A (en) * | 1986-08-08 | 1990-11-06 | Glaxo Group Limited | Pharmaceutical compositions for the treatment of occlusive vascular diseases |
US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5821260A (en) * | 1992-10-30 | 1998-10-13 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5792787A (en) * | 1995-06-07 | 1998-08-11 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670825A1 (de) * | 1967-03-20 | 1971-03-11 | Bayer Ag | Verfahren zur Herstellung von 1,4-Dihydropyridinderivaten |
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
US4154822A (en) * | 1976-08-02 | 1979-05-15 | The University Of Chicago | Polysaccharide for enhancement of cardiac output |
DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2844595A1 (de) * | 1978-10-13 | 1980-04-30 | Bayer Ag | Acylaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
ATE20064T1 (de) * | 1982-07-22 | 1986-06-15 | Pfizer | Anti-ischaemische und antihypertensive dihydropyridin-derivate. |
PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
GB8306666D0 (en) * | 1983-03-10 | 1983-04-13 | Pfizer Ltd | Therapeutic agents |
EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
-
1984
- 1984-08-17 GB GB848421039A patent/GB8421039D0/en active Pending
-
1985
- 1985-07-30 US US06/760,705 patent/US4694012A/en not_active Expired - Fee Related
- 1985-08-05 ZA ZA855910A patent/ZA855910B/xx unknown
- 1985-08-15 GB GB8520486A patent/GB2163050B/en not_active Expired
- 1985-08-15 GB GB08520487A patent/GB2167745B/en not_active Expired
- 1985-08-16 MX MX584085A patent/MX5840A/es unknown
- 1985-08-19 DD DD85279811A patent/DD236093A5/de not_active IP Right Cessation
-
1987
- 1987-08-03 US US07/081,526 patent/US4900750A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4694012A (en) | 1987-09-15 |
GB8520486D0 (en) | 1985-09-18 |
US4900750A (en) | 1990-02-13 |
GB2167745B (en) | 1987-09-03 |
GB8421039D0 (en) | 1984-09-19 |
ZA855910B (en) | 1987-03-25 |
MX5840A (es) | 1993-11-01 |
GB8520487D0 (en) | 1985-09-18 |
GB2163050B (en) | 1989-03-22 |
GB2167745A (en) | 1986-06-04 |
GB2163050A (en) | 1986-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69229341T2 (de) | N-arylheteroarylalkylimidazol-2-onverbindungen für die behandlung von kreislaufstörungen | |
DE3788385T2 (de) | Pyrimidin-Derivate. | |
DD224593A5 (de) | Verfahren zur herstellung von 1-heteroaryl-4-[-2,5-pyrrolidindion-1-yl]alkyl]piperazinderivaten | |
EP0172029B1 (en) | 1,4-dihydropyridines | |
EP0624583A1 (de) | Substituierte Mono- und Bipyridylmethylpyridone als Angiotensin II Antagonisten | |
DE3874358T2 (de) | 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen. | |
DE3512995A1 (de) | Dihydropyridinyldicarbonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel | |
DE2940833C2 (es) | ||
DE3522579C2 (de) | Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben | |
DE69211568T2 (de) | 1-akylheteroarylalkyl substituierte 1-h-1,2,4-triazole zur behandlung von durchblutungsstörungen | |
EP0610698B1 (de) | Substituierte Imidazo(4,5-b)pyridine und Benzimidazole als Angiotensin II Antagoniste | |
DE4215588A1 (de) | Biphenylmethyl-substituierte Pyridone | |
DD236093A5 (de) | Verfahren zur herstellung von 1,4-dihydropyridinen | |
DE3874394T2 (de) | 1,3-dioxane. | |
AU601946B2 (en) | 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders | |
DE4301900A1 (de) | 2-Oxochinolin-1-yl-methylphenylessigsäurederivate | |
DD206994A5 (de) | Verfahren zur herstellung von pyridinderivaten | |
EP0630896A1 (de) | Substituierte Mono- und Bipyridylmethylderivate als Angiotensin II Antagonist | |
DE3586817T2 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69107137T2 (de) | 1-(alkoxy-iminoalkyl)imidazolderivate. | |
EP0342182A1 (de) | Derivate von 5-Aminomethyl-2-furanmethanol, ihre Herstellung und Verwendung | |
DE3751562T2 (de) | 1,4-Dihydropyridine. | |
DE4314963A1 (de) | Substituierte Pyridine und 2-Oxo-1,2-dihydropyridine | |
KR960001916B1 (ko) | 1,4-디하이드로피리딘 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |